BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27878971)

  • 1. Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.
    Chen Y; Huang W; Chen F; Hu G; Li F; Li J; Xuan A
    Cancer Med; 2016 Dec; 5(12):3564-3571. PubMed ID: 27878971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
    Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of drug resistance by human pregnane X receptor in breast cancer.
    Chen Y; Tang Y; Chen S; Nie D
    Cancer Biol Ther; 2009 Jul; 8(13):1265-72. PubMed ID: 19746521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
    Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
    J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
    Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
    Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXR.
    Kim SW; Md Hasanuzzaman ; Cho M; Kim NH; Choi HY; Han JW; Park HJ; Oh JW; Shin JG
    Cell Signal; 2017 Feb; 31():124-134. PubMed ID: 28077325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
    Masuyama H; Nakamura K; Nobumoto E; Hiramatsu Y
    Int J Oncol; 2016 Sep; 49(3):1211-20. PubMed ID: 27572875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pregnane X receptor and resistance to chemotherapy in prostate cancer.
    Chen Y; Tang Y; Wang MT; Zeng S; Nie D
    Cancer Res; 2007 Nov; 67(21):10361-7. PubMed ID: 17974979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.
    Doricakova A; Theile D; Weiss J; Vrzal R
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):49-59. PubMed ID: 27678410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
    Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
    Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pregnane X receptor expression on drug resistance in breast cancer.
    Qiao EQ; Yang HJ
    Oncol Lett; 2014 Apr; 7(4):1191-1196. PubMed ID: 24944691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
    Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioimaging real-time PXR-dependent mdr1a gene regulation in mdr1a.fLUC reporter mice.
    Gu L; Chen J; Synold TW; Forman BM; Kane SE
    J Pharmacol Exp Ther; 2013 Jun; 345(3):438-45. PubMed ID: 23532932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ; Li G; Luo QS; Li HM
    IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.
    Mensah-Osman EJ; Thomas DG; Tabb MM; Larios JM; Hughes DP; Giordano TJ; Lizyness ML; Rae JM; Blumberg B; Hollenberg PF; Baker LH
    Cancer; 2007 Mar; 109(5):957-65. PubMed ID: 17279585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
    Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
    Tang XH; Lu MS; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.